Friday, June 30, 2023
US Medical Innovations, LLC (USMI), a subsidiary of US Patent Innovations, LLC, has announced that it has received FDA approval for its Canady Flex RoboWrist™. This innovative surgical device is designed for use in both open and laparoscopic procedures and has already gained approval for use in the Middle East, Europe, and Asia.
The Canady Flex RoboWrist™ is a motorized, hand-held surgical instrument that offers full articulation and measures 5mm in diameter. It comes with a range of end effectors, including a hook, scissors, needle driver, and dissector. With 3 degrees of freedom and 360 degrees of rotation, the device provides precise control during tissue dissection, transection, and suturing in various surgical procedures such as laparoscopic, urologic, gynecologic, general, and thoracic surgeries.
This advanced robotic surgery device represents a significant advancement in laparoscopic surgical technology. It enables bidirectional deflection and unlimited rotation of the distal jaws, allowing surgeons improved access to surgical sites and enhanced laparoscopic suturing capabilities.
The Canady Flex RoboWrist™ offers several key features and benefits. Its exceptional precision reduces the risk of human error and enhances surgical outcomes. The device is equipped with state-of-the-art automation and intelligent control systems, optimizing surgical workflows and saving valuable time in the operating room. Surgeons can focus more on critical decision-making, while the device assists with repetitive tasks, improving overall efficiency.
Another advantage of the Canady Flex RoboWrist™ is its cost-effectiveness. It can be autoclaved up to 50 times and does not require the use of disposables, making it a reliable and economical option for surgical procedures.
With FDA approval in place, USMI is now able to introduce the Canady Flex RoboWrist™ to the United States, providing surgeons with a revolutionary tool that has the potential to redefine the possibilities of robotic-assisted surgical procedures.
Source: businesswire.com/
